3-aminobenzamide has been researched along with Arterial Occlusive Diseases in 1 studies
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The specific PARP inhibitor 3-aminobenzamide was injected 10 min before induction of ischemia at a dosage of 5, 10, and 20 mg/kg intracerebroventricularly." | 1.31 | The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia. ( Bardenheuer, HJ; Kopitz, J; Martin, E; Plaschke, K; Weigand, MA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plaschke, K | 1 |
| Kopitz, J | 1 |
| Weigand, MA | 1 |
| Martin, E | 1 |
| Bardenheuer, HJ | 1 |
1 other study available for 3-aminobenzamide and Arterial Occlusive Diseases
| Article | Year |
|---|---|
The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia.
Topics: Animals; Arterial Occlusive Diseases; Benzamides; Brain Ischemia; Carotid Artery, Common; Cerebral C | 2000 |